OAM
TECH icon

Ostrum Asset Management’s Bio-Techne TECH Stock Holding History

Ostrum Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,860
Closed -$109K – 635
2025
Q1 		$109K Sell
1,860
-49
-3% -$3.32K 0.01% 564
2024
Q4 		$138K Sell
1,909
-6,487
-77% -$476K 0.01% 550
2024
Q3 		$671K Buy
8,396
+102
+1% +$7.67K 0.06% 364
2024
Q2 		$594K Sell
8,294
-646
-7% -$47.5K 0.05% 370
2024
Q1 		$629K Hold
8,940
– – 0.05% 410
2023
Q4 		$690K Sell
8,940
-5,101
-36% -$336K 0.06% 374
2023
Q3 		$956K Sell
14,041
-6,612
-32% -$522K 0.09% 322
2023
Q2 		$1.69M Buy
20,653
+18
+0.1% +$1.45K 0.14% 218
2023
Q1 		$1.53M Buy
+20,635
New +$1.59M 0.13% 223

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ostrum Asset Management's TECH Position: Q2 2025 in Review

Ostrum Asset Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 1,860 shares — an estimated $109K sold.

Ostrum Asset Management first reported a position in TECH in Q1 2023 and held it in 9 quarters. The position peaked at $1.69M in Q2 2023. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Ostrum Asset Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • Ostrum Asset Management sold 1,860 Bio-Techne shares in Q2 2025, an estimated $109K.
  • Ostrum Asset Management first reported a position in Bio-Techne in Q1 2023 and held it in 9 quarters.
  • Ostrum Asset Management's Bio-Techne position peaked at $1.69M in Q2 2023.
  • 556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Ostrum Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.